Citadel Advisors’s CAREFUSION CORPORATION CFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-2,700
Closed -$160K 9213
2014
Q4
$160K Sell
2,700
-3,900
-59% -$224K ﹤0.01% 6231
2014
Q3
$299K Sell
6,600
-1,600
-20% -$72.1K ﹤0.01% 5267
2014
Q2
$364K Sell
8,200
-19,200
-70% -$795K ﹤0.01% 4794
2014
Q1
$1.1M Buy
27,400
+11,000
+67% +$445K ﹤0.01% 3308
2013
Q4
$653K Sell
16,400
-1,700
-9% -$66.1K ﹤0.01% 3701
2013
Q3
$668K Sell
18,100
-84,000
-82% -$3.14M ﹤0.01% 3512
2013
Q2
$3.76M Buy
+102,100
New +$3.61M 0.01% 1840

Other funds holding CFN

Citadel Advisors's CFN Position: Q1 2015 in Review

Citadel Advisors sold out of CAREFUSION CORPORATION (CFN) in Q1 2015, closing a stake of 3,505,728 shares — an estimated $208M sold.

Citadel Advisors first reported a position in CFN in Q2 2013 and held it in 7 quarters. The position peaked at $208M in Q4 2014. 3 funds tracked by Wall St. Rank hold CFN as of Q1 2015.

  • Citadel Advisors reported no remaining CAREFUSION CORPORATION position as of Q1 2015 after selling out during the quarter.
  • Citadel Advisors sold 3,505,728 CAREFUSION CORPORATION shares in Q1 2015, an estimated $208M.
  • Citadel Advisors first reported a position in CAREFUSION CORPORATION in Q2 2013 and held it in 7 quarters.
  • Citadel Advisors's CAREFUSION CORPORATION position peaked at $208M in Q4 2014.
  • 3 funds tracked by Wall St. Rank held CAREFUSION CORPORATION as of Q1 2015.

Based on Citadel Advisors's 13F filing for Q1 2015, filed 15 May 2015.